Liu X, Qian K, Su L, Tian X, Zhao X, Wang T
Eur J Med Res. 2025; 30(1):74.
PMID: 39905556
PMC: 11792379.
DOI: 10.1186/s40001-025-02327-7.
Zhou M, Zhang Y, Song W
Clin Transl Oncol. 2024; .
PMID: 39589706
DOI: 10.1007/s12094-024-03802-z.
Li H, Qiao L, Kong M, Fang H, Yan Z, Guo R
Sci Rep. 2024; 14(1):26994.
PMID: 39506070
PMC: 11541849.
DOI: 10.1038/s41598-024-78467-3.
Jiang X, Wu X, Lu M, Fan W, Song J, Song F
Front Oncol. 2024; 14:1448502.
PMID: 39386192
PMC: 11461168.
DOI: 10.3389/fonc.2024.1448502.
Li T, Liu J, Zhou Y, Huang S, Wang D, Chen J
Cancer Med. 2024; 13(10):e7227.
PMID: 38770632
PMC: 11106684.
DOI: 10.1002/cam4.7227.
A programmed cell death-related gene signature to predict prognosis and therapeutic responses in liver hepatocellular carcinoma.
Gu X, Pan J, Li Y, Feng L
Discov Oncol. 2024; 15(1):71.
PMID: 38466483
PMC: 10928056.
DOI: 10.1007/s12672-024-00924-2.
Construction of endothelial cell signatures for predicting the diagnosis, prognosis and immunotherapy response of bladder cancer via machine learning.
Fu Y, Sun S, Shi D, Bi J
J Cell Mol Med. 2024; 28(6):e18155.
PMID: 38429911
PMC: 10907833.
DOI: 10.1111/jcmm.18155.
The Pathogenesis of Systemic Sclerosis: The Origin of Fibrosis and Interlink with Vasculopathy and Autoimmunity.
Ko J, Noviani M, Chellamuthu V, Albani S, Low A
Int J Mol Sci. 2023; 24(18).
PMID: 37762589
PMC: 10532389.
DOI: 10.3390/ijms241814287.
Integrative analysis revealed that distinct cuprotosis patterns reshaped tumor microenvironment and responses to immunotherapy of colorectal cancer.
Xu X, Ding C, Zhong H, Qin W, Shu D, Yu M
Front Immunol. 2023; 14:1165101.
PMID: 37006250
PMC: 10060625.
DOI: 10.3389/fimmu.2023.1165101.
Integrated pan-cancer analysis and experimental verification of the roles of tropomyosin 4 in gastric cancer.
Guo Q, Zhao L, Yan N, Li Y, Guo C, Dang S
Front Immunol. 2023; 14:1148056.
PMID: 36993958
PMC: 10041708.
DOI: 10.3389/fimmu.2023.1148056.
A phase I study of an adenoviral vector delivering a MUC1/CD40-ligand fusion protein in patients with advanced adenocarcinoma.
Tan T, Ang W, Wang W, Chong H, Tan S, Cheong R
Nat Commun. 2022; 13(1):6453.
PMID: 36307410
PMC: 9616917.
DOI: 10.1038/s41467-022-33834-4.
A novel T-cell proliferation-associated regulator signature pre-operatively predicted the prognostic of bladder cancer.
Hou J, Wen X, Lu Z, Wu G, Yang G, Tang C
Front Immunol. 2022; 13:970949.
PMID: 36211359
PMC: 9539738.
DOI: 10.3389/fimmu.2022.970949.
How does age determine the development of human immune-mediated arthritis?.
Degboe Y, Vastert S, Prakken B, McInnes I
Nat Rev Rheumatol. 2022; 18(9):501-512.
PMID: 35948692
PMC: 9363867.
DOI: 10.1038/s41584-022-00814-3.
Toward Molecular Stratification and Precision Medicine in Systemic Sclerosis.
Noviani M, Chellamuthu V, Albani S, Low A
Front Med (Lausanne). 2022; 9:911977.
PMID: 35847779
PMC: 9279904.
DOI: 10.3389/fmed.2022.911977.
DDOST Correlated with Malignancies and Immune Microenvironment in Gliomas.
Chang X, Pan J, Zhao R, Yan T, Wang X, Guo C
Front Immunol. 2022; 13:917014.
PMID: 35812432
PMC: 9260604.
DOI: 10.3389/fimmu.2022.917014.
Pro-Inflammatory Derangement of the Immuno-Interactome in Heart Failure.
Kumar P, Lim A, Poh S, Nur Hazirah S, Chua C, Sutamam N
Front Immunol. 2022; 13:817514.
PMID: 35371099
PMC: 8964981.
DOI: 10.3389/fimmu.2022.817514.
Juvenile idiopathic arthritis.
Martini A, Lovell D, Albani S, Brunner H, Hyrich K, Thompson S
Nat Rev Dis Primers. 2022; 8(1):5.
PMID: 35087087
DOI: 10.1038/s41572-021-00332-8.
Development and Validation of a Novel Hypoxia-Related Long Noncoding RNA Model With Regard to Prognosis and Immune Features in Breast Cancer.
Gu P, Zhang L, Wang R, Ding W, Wang W, Liu Y
Front Cell Dev Biol. 2022; 9:796729.
PMID: 34977036
PMC: 8716768.
DOI: 10.3389/fcell.2021.796729.
The Pyroptosis-Related Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Gastric Cancer.
Shao W, Yang Z, Fu Y, Zheng L, Liu F, Chai L
Front Cell Dev Biol. 2021; 9:676485.
PMID: 34179006
PMC: 8226259.
DOI: 10.3389/fcell.2021.676485.
A Virus-Specific Immune Rheostat in the Immunome of Patients Recovering From Mild COVID-19.
Yeo J, Leong J, Tay S, Nadua K, Anderson D, Lim A
Front Immunol. 2021; 12:674279.
PMID: 34113347
PMC: 8185226.
DOI: 10.3389/fimmu.2021.674279.
